-
Study aim
-
Comparison Efficacy of extract plants of Zingiber, Cinnamon zeylanicum, Zataria multiflora with standard treatment in adult patients with moderate to severe symptoms of Covid 19
-
Design
-
In this blinded randomized parallel clinical trial, 80 Patients are allocated randomly with simple sequential allocation in one of the two groups (herbal extract or standard protocol) and receive the intervention of that group.
-
Settings and conduct
-
Adult patients with Covid 19 are randomly assigned to one of the two groups and receive appropriate intervention in the control group according to the national protocol. In the second group, in addition to the standard daily intervention, a capsule of a combined extract of 3 plants is consumed for one week every morning after a meal with a glass of water. Days 3, 0, 5, 7, 10 and 14 of the patients in terms of temperature, presence and severity of cough, dyspnea, number of breaths, oxygen saturation of the blood (pulse oximetry), blood pressure and general condition Check . Basic serum samples and LFT and IL4 and 6 and imaging based on the standard protocol are at the beginning and on days 7, and if a specific complication develops extract discontinued and standard treatment will be done.
-
Participants/Inclusion and exclusion criteria
-
Inclusion criteria:Adult patients (18-75 year) suffering from nCovid-19 with moderate to severe symptoms having informed consent form
Exclusion criteria:Poor condition patients,inability to take oral drugs, and those with a history of herbal or medicinal allergy.
-
Intervention groups
-
According to the National Protocol,patients with Covid-19 in addition to the standard treatment n daily consumed one capsule of 3 plant extracts for one week every morning after a meal with a glass of water.
-
Main outcome variables
-
Cough severity,dyspnea,temperature,respiratory rate,oxygen saturation blood pressure and change in imaging